Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2020

Open Access 01-12-2020 | Hyperaldosteronism | Case report

Seizure and coma secondary to Conn’s syndrome: a case report

Authors: Eiman Alseddeeqi, Ajda Altinoz, Najla Ben Ghashir

Published in: Journal of Medical Case Reports | Issue 1/2020

Login to get access

Abstract

Background

Conn’s syndrome is a curable condition if identified properly. It is characterized by autonomous secretion of aldosterone from the adrenal gland cortex. Its morbidity is related to the increased risk of cardiovascular diseases.

Case presentation

We report the case of a 48-year-old man of African descent presenting with generalized tonic-clonic seizure and coma secondary to hypertensive encephalopathy. A biochemical evaluation revealed a very high aldosterone level and an undetectable renin level, both are compatible with primary aldosteronism. The presentation of the following confirms the diagnosis of primary aldosteronism: spontaneous hypokalemia, an undetectable renin level, and a high aldosterone level. Abdominal computed tomography revealed a left adrenal adenoma. Adrenal venous sampling confirmed lateralization of aldosterone excretion from the left adrenal gland. Our patient underwent left laparoscopic adrenalectomy that confirmed a left functional adrenal adenoma. After 12 months of follow up, his hypertension was controlled on only one antihypertensive drug which was down from four drugs preoperatively.

Conclusion

Conn’s syndrome, in this case, was complicated by coma secondary to seizure. Adrenalectomy normalized the hypokalemia and improved resistant hypertension. Potassium supplementation and several antihypertensives were discontinued as our patient became normokalemic and normotensive on one antihypertensive agent.
Literature
1.
go back to reference Conn JW. Primary aldosteronism. J Lab Clin Med. 1955;45(4):661–4.PubMed Conn JW. Primary aldosteronism. J Lab Clin Med. 1955;45(4):661–4.PubMed
2.
go back to reference Feig BW, Ching CD. The MD Anderson Surgical Oncology Handbook. In: Duncan CB, Lee JE, editors. Adrenal Tumors. 6th edn. Philadelphia: Wolters Kluwer; 2019. p. 696–702. Feig BW, Ching CD. The MD Anderson Surgical Oncology Handbook. In: Duncan CB, Lee JE, editors. Adrenal Tumors. 6th edn. Philadelphia: Wolters Kluwer; 2019. p. 696–702.
3.
go back to reference Kayser SC, Dekkers T, Groenewound HJ, Van der Wilt GJ, Carel Bakx J, Van der Wel MC, Hernus AR, Lenders JW, Deinum J. Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A systemic Review and Meta-Regression Analysis. J Clin Endocrinol Metab. 2016;101(7):2826–35.CrossRef Kayser SC, Dekkers T, Groenewound HJ, Van der Wilt GJ, Carel Bakx J, Van der Wel MC, Hernus AR, Lenders JW, Deinum J. Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A systemic Review and Meta-Regression Analysis. J Clin Endocrinol Metab. 2016;101(7):2826–35.CrossRef
4.
go back to reference Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. PAPY study investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293–300.CrossRef Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. PAPY study investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293–300.CrossRef
5.
go back to reference Conn JW, Knopf RF, Nesbit RM. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg. 1964;107:159–72.CrossRef Conn JW, Knopf RF, Nesbit RM. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg. 1964;107:159–72.CrossRef
6.
go back to reference Valloton MB. Primary hyperaldosteronism. I. Diagnosis of primary hyperaldosteronism. Clin Endocrinol. 1996;45(1):47–52.CrossRef Valloton MB. Primary hyperaldosteronism. I. Diagnosis of primary hyperaldosteronism. Clin Endocrinol. 1996;45(1):47–52.CrossRef
7.
go back to reference Young WF. Pheochromocytoma and primary hyperaldosteronism: diagnostic approaches. Endocrinol Metab Clin N Am. 1997;26(4):801–29.CrossRef Young WF. Pheochromocytoma and primary hyperaldosteronism: diagnostic approaches. Endocrinol Metab Clin N Am. 1997;26(4):801–29.CrossRef
8.
go back to reference Ganguly A. Primary hyperaldosteronism. N Engl J Med. 1998;339(25):1828–34.CrossRef Ganguly A. Primary hyperaldosteronism. N Engl J Med. 1998;339(25):1828–34.CrossRef
9.
go back to reference Stewart PM. Mineralocorticoid hypertension. Lancet. 1999;353(9161):1341–7.CrossRef Stewart PM. Mineralocorticoid hypertension. Lancet. 1999;353(9161):1341–7.CrossRef
10.
go back to reference Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, et al. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013;98(12):4826–33.CrossRef Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, et al. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013;98(12):4826–33.CrossRef
11.
go back to reference Celen O, O’Brien MJ, Melby JC, Beazley RM. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg. 1996;131:646.CrossRef Celen O, O’Brien MJ, Melby JC, Beazley RM. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg. 1996;131:646.CrossRef
12.
go back to reference Rutherford JC, Taylor WL, Stowasser M, Gordon RD. Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production. World J Surg. 1998;22(12):1243–5.CrossRef Rutherford JC, Taylor WL, Stowasser M, Gordon RD. Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production. World J Surg. 1998;22(12):1243–5.CrossRef
13.
go back to reference Sukor N, Kogovsek C, Gordon RD, Robson D, Stowasser M. Improvement in quality of life as well as in blood pressure and biochemical status following laparoscopic adrenalectomy in patients with unilateral primary aldosteronism - a pilot study. J Clin Endocrinol Metab. 2010;95(3):1360–4.CrossRef Sukor N, Kogovsek C, Gordon RD, Robson D, Stowasser M. Improvement in quality of life as well as in blood pressure and biochemical status following laparoscopic adrenalectomy in patients with unilateral primary aldosteronism - a pilot study. J Clin Endocrinol Metab. 2010;95(3):1360–4.CrossRef
14.
go back to reference Lim PO, Young WF, MacDonald TM. A review of the medical treatment of primary aldosteronism. J Hypertens. 2001;19(3):353–61.CrossRef Lim PO, Young WF, MacDonald TM. A review of the medical treatment of primary aldosteronism. J Hypertens. 2001;19(3):353–61.CrossRef
15.
go back to reference Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective’ screening of hypertensive patients. J Hypertens. 2003;21(11):2149–57.CrossRef Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective’ screening of hypertensive patients. J Hypertens. 2003;21(11):2149–57.CrossRef
16.
go back to reference Lim PO, Jung RT, MacDonald TM. Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study. Br J Clin Pharmacol. 1999;48(5):756–60.CrossRef Lim PO, Jung RT, MacDonald TM. Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study. Br J Clin Pharmacol. 1999;48(5):756–60.CrossRef
17.
go back to reference Bortolotto LA, Cesena FH, Jatene FB, Silva HB. Malignant hypertension and hypertensive encephalopathy in primary aldosteronism caused by adrenal adenoma. Arq Bras Cardiol. 2003;81(1):97–100. 93-6.CrossRef Bortolotto LA, Cesena FH, Jatene FB, Silva HB. Malignant hypertension and hypertensive encephalopathy in primary aldosteronism caused by adrenal adenoma. Arq Bras Cardiol. 2003;81(1):97–100. 93-6.CrossRef
18.
go back to reference Labinson PT, White WB, Tendler BE, Mansoor GA. Primary hyperaldosteronism associated with hypertensive emergencies. Am J Hypertens. 2006;19(6):623–7.CrossRef Labinson PT, White WB, Tendler BE, Mansoor GA. Primary hyperaldosteronism associated with hypertensive emergencies. Am J Hypertens. 2006;19(6):623–7.CrossRef
19.
go back to reference Miyaji Y, Kawabata Y, Joki H, Seki S, Mori K, Kamide T, Tamase A, Shima H, Nomura M, Kitamura Y, Nakaguchi H, Minami T, Tsunoda T, Sasaki M, Yamada M, Tanaka M. Primary aldosteronism in patients with acute stroke: prevalence and diagnosis during initial hospitalization. BMC Neurol. 2016;16:177.CrossRef Miyaji Y, Kawabata Y, Joki H, Seki S, Mori K, Kamide T, Tamase A, Shima H, Nomura M, Kitamura Y, Nakaguchi H, Minami T, Tsunoda T, Sasaki M, Yamada M, Tanaka M. Primary aldosteronism in patients with acute stroke: prevalence and diagnosis during initial hospitalization. BMC Neurol. 2016;16:177.CrossRef
20.
go back to reference Funder JW, Carey RM, Mantero F, Murad MH, Shibata MRH, Stowasser M, Young WF Jr. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(5):1889–916.CrossRef Funder JW, Carey RM, Mantero F, Murad MH, Shibata MRH, Stowasser M, Young WF Jr. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(5):1889–916.CrossRef
21.
go back to reference Zhou Y, Zhang M, Ke S, Liu L. Hypertension outcomes of adrenalectomy in patients with primary aldosteronism: a systemic review and meta-analysis. BMC Endocr Disord. 2017;17(1):61.CrossRef Zhou Y, Zhang M, Ke S, Liu L. Hypertension outcomes of adrenalectomy in patients with primary aldosteronism: a systemic review and meta-analysis. BMC Endocr Disord. 2017;17(1):61.CrossRef
22.
go back to reference Lee FT, Elaraj D. Evaluation and Management of Primary Hyperaldosteronism. Surg Clin North Am. 2019;99(4):731–45.CrossRef Lee FT, Elaraj D. Evaluation and Management of Primary Hyperaldosteronism. Surg Clin North Am. 2019;99(4):731–45.CrossRef
23.
go back to reference Byrd JB, Turcu AF, Auchus RJ. Primary Aldosteronism. Circulation. 2018;138(8):823–35.CrossRef Byrd JB, Turcu AF, Auchus RJ. Primary Aldosteronism. Circulation. 2018;138(8):823–35.CrossRef
24.
go back to reference Schilbach K, Junnila RK, Bidlingmaier M. Aldosterone to renin as Screening Tool in Primary Aldosteronism. Exp Clin Endocrinol Diabetes. 2019;127(2–03):84–92.PubMed Schilbach K, Junnila RK, Bidlingmaier M. Aldosterone to renin as Screening Tool in Primary Aldosteronism. Exp Clin Endocrinol Diabetes. 2019;127(2–03):84–92.PubMed
25.
go back to reference Wierdak M, Sokołowski G, Natkaniec M, Morawiec-Sławek K, Małczak P, Major P, Hubalewska-Dydejczyk A, Budzyński A, Pędziwiatr M. Short- and long-term results of laparoscopic adrenalectomy for Conn’s syndrome. Wideochir Inne Tech Maloinwazyjne. 2018;13(3):292–8.PubMedPubMedCentral Wierdak M, Sokołowski G, Natkaniec M, Morawiec-Sławek K, Małczak P, Major P, Hubalewska-Dydejczyk A, Budzyński A, Pędziwiatr M. Short- and long-term results of laparoscopic adrenalectomy for Conn’s syndrome. Wideochir Inne Tech Maloinwazyjne. 2018;13(3):292–8.PubMedPubMedCentral
26.
go back to reference Winship KM, Winstanley JHR, Hunter JM. Anaesthesia for Conn’s Syndrome. Anaesthesia. 1999;54(9):564–74. Winship KM, Winstanley JHR, Hunter JM. Anaesthesia for Conn’s Syndrome. Anaesthesia. 1999;54(9):564–74.
27.
go back to reference Shipton EA, Hugo JM. Primary aldosteronism and its importance to the anaesthesist. S Afr Med J. 1982;62:60–3.PubMed Shipton EA, Hugo JM. Primary aldosteronism and its importance to the anaesthesist. S Afr Med J. 1982;62:60–3.PubMed
28.
go back to reference Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. PASO study investigators. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5(9):689–99.CrossRef Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. PASO study investigators. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5(9):689–99.CrossRef
Metadata
Title
Seizure and coma secondary to Conn’s syndrome: a case report
Authors
Eiman Alseddeeqi
Ajda Altinoz
Najla Ben Ghashir
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2020
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-020-02434-5

Other articles of this Issue 1/2020

Journal of Medical Case Reports 1/2020 Go to the issue